Wim Mol (PhD)
Chief Executive Officer
Wim Mol has 30 years of international experience in general management, commercial, and research and development positions in the pharmaceutical and biotech industry.
Before joining Catapult Therapeutics in 2017, he was CEO at Pepscan, which he transitioned from a hybrid R&D/services organization into a fast-growing profitable peptide services company. Before Pepscan, he was vice president of Schering-Plough, where he was responsible for the global scientific development and commercialization of a phase III asset. Prior to that, he held multiple executive roles within the Organon group, including executive director of global marketing for the women’s health franchise, general manager of a joint venture between Organon and Sanofi in the USA, and country manager positions in Chili and the Netherlands. Dr Mol has an MSc in pharmacy and a PhD in pharmacology from the University of Groningen.
Wim Mol has 30 years of international experience in general management, commercial, and development positions in pharma and biotech… Read moreRead less